MbrlCatalogueTitleDetail

Do you wish to reserve the book?
中国埃克替尼治疗非小细胞肺癌专家共识(2016年版)
中国埃克替尼治疗非小细胞肺癌专家共识(2016年版)
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
中国埃克替尼治疗非小细胞肺癌专家共识(2016年版)
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
中国埃克替尼治疗非小细胞肺癌专家共识(2016年版)
中国埃克替尼治疗非小细胞肺癌专家共识(2016年版)

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
中国埃克替尼治疗非小细胞肺癌专家共识(2016年版)
中国埃克替尼治疗非小细胞肺癌专家共识(2016年版)
Journal Article

中国埃克替尼治疗非小细胞肺癌专家共识(2016年版)

2016
Request Book From Autostore and Choose the Collection Method
Overview
2015年中国肺癌新发病例73.3万,死亡病例61.0万。发病率和死亡率均居恶性肿瘤的首位。80%多的肺癌患者为非小细胞肺癌(non-small cell lung cancer ,NSCLC),70%左右的患者数就诊时已属晚期,失去了手术治疗的机会。化疗是晚期NSCLC治疗的主要手段,其地位虽然没有发生根本的动摇,但其疗效已达到平台,同时化疗的毒副反应也限制了其广泛的临床应用。
Publisher
100021北京,国家癌症中心/北京协和医学院中国医学科学院肿瘤医院内科,抗肿瘤分子靶向药物临床研究北京市重点实验室%河北医科大学第四医院,石家庄,050000%北京大学肿瘤医院,北京,100142%天津医科大学肿瘤医院,天津,300070%第二军医大学长海医院,上海,200433%复旦大学附属中山医院,上海,200032%江苏省肿瘤医院,南京,210009%解放军第307医院,北京,100071%解放军总医院,北京,100853%江苏省人民医院,南京,210029%青海大学附属医院,西宁,810000%广州医科大学附属第一医院,广州,510000%浙江省肿瘤医院,杭州,310022%首都医科大学附属北京市胸科医院,北京,101149%哈尔滨医科大学附属肿瘤医院,哈尔滨,150081%中山大学附属第一医院,广州,510080%南方医科大学南方医院,广州,510515%同济大学附属上海市肺科医院,上海,200433%浙江大学附属第一医院,杭州,310003%上海交通大学附属胸科医院,上海,200030%常州市第四人民医院,常州,213001%福建省肿瘤医院,福州,350014

MBRLCatalogueRelatedBooks